March 31, 2025 |
OPEN Health Group is pleased to announce the appointment of Matt D’Auria as its new Chief Executive Officer (CEO). Based in the US, Matt brings more than 25 years of experience in medical affairs and scientific commercialization to his new role, where he will focus on refining and deploying an innovation and growth strategy.

March 31, 2025, London, UK – OPEN Health Group is pleased to announce the appointment of Matt D’Auria as its new Chief Executive Officer (CEO). Based in the US, Matt brings more than 25 years of experience in medical affairs and scientific commercialization to his new role, where he will focus on refining and deploying an innovation and growth strategy.
Before joining OPEN Health, he served as CEO of the Healthcare Consultancy Group (HCG), a medical communications business within Omnicom. During his tenure, he led enterprise client partnerships, expanded global teams, and developed market access strategies that helped drive consistent growth. Matt has also held agency leadership roles at Envision Communications and Syneos Health, and he cites a diverse set of oncology marketing and sales roles at AstraZeneca for shaping his approach to scientific commercialization.
“I am truly honored to lead OPEN Health at this time,” said Matt. “We have an incredible team, a strong foundation, and an unwavering commitment to providing services that play an important role in the translation of scientific complexity into clinical meaning, bringing medicine closer to patients in need.”
“Matt’s global experience, commitment to scientific excellence, and innovation mindset align perfectly with OPEN Health’s core values and growth strategy,” said Dave King, Chairman of OPEN Health’s Board of Directors. “We are confident that he will lead us to even greater heights, and we are excited for the future under his leadership.”
Matt succeeds Vivid Sehgal, Interim CEO, who will continue his journey with OPEN Health by joining the company’s board as a Non-Executive Director.
About OPEN Health
OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. OPEN Health is a flexible global organization that solves complex healthcare challenges across consulting, HEOR and market access, scientific communications, patient engagement, and creative omnichannel communications. To learn more, visit www.openhealthgroup.com
Contact:
Candice Subero, VP of Global Marketing
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...
Medical affairs teams must train regularly to stay up to date with existing and emerging therapy areas, products, and devices. But finding time to train is tough, so what can...
We asked Laura Glover to give us an insight into her role as a PR Account Director at OPEN Health
OPEN Health has today announced the acquisition of North West UK-based medical communications agency Spirit.
We are delighted to announce our selection in the top 50 of 100 North American healthcare agencies as ranked by Medical, Marketing & Media (MM&M).
OPEN Health is moving to one brand to create a world-class integrated services model
To mark Rare Disease Day 2021 on Sunday 28 February, OPEN Health will be intentionally quiet on all LinkedIn channels from 26 February to 1 March in order not to...
If the heart of the medical affairs industry is ultimately improving patient outcomes, internal training is the regenerative liver. Med affairs professionals need to regularly update their scientific knowledge and...
How fantastic is it to see that the National Organisation for Rare Disorders (NORD) has followed up on a survey undertaken in the late 80’s to pressure test progress and identify...
